ANDA 80425, held by Mission Pharma. Hydrocortisone.
As of Nov 13, 2026, ANDA 80425 (Texacort), held by Mission Pharma, was first approved by FDA on Dec 22, 1971, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 1971 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Texacort1% ยท solution;topical | Hydrocortisone | Discontinued |
| May 19, 1992 | Supplement 10Manufacturing | Approved | None posted |
| May 19, 1992 | Supplement 11Manufacturing | Approved | None posted |
| Sep 6, 1990 | Supplement 12Labeling | Approved | None posted |
| Oct 12, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Oct 12, 1989 | Supplement 8Manufacturing | Approved | None posted |
| Oct 12, 1989 | Supplement 9Labeling | Approved | None posted |
| Dec 22, 1971 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters